Zhonghua Gan Zang Bing Za Zhi. 2024 Aug 20;32(8):718-725. doi: 10.3760/cma.j.cn501113-20240723-00340.
The prevalence of hepatitis B represents a significant public health concern with a heavy disease burden. In China, there is still a big gap between the current diagnosis and treatment rates of hepatitis B and the goal of eliminating viral hepatitis as a public health threat by 2030 set by the World Health Organization (WHO). In order to achieve the WHO goal and the goal of 2030 Healthy China Outline, the Chinese Preventive Medicine Association organized domestic experts in the fields of clinical medicine, public health and clinical laboratory medicine to develop the Expert Recommendations on Screening, Testing and Management for Hepatitis B Virus Infection in Adults after several rounds of discussion based on comprehensive review of relevant domestic and international guidelines and literatures, the purpose is to facilitate universal screening of hepatitis B virus(HBV)infection in adults and provide practical guidance on disease assessment, treatment and long-term follow-up management of people infected with HBV and vaccination for people susceptible to HBV infection,thus promoting the elimination of the threat of hepatitis B.
乙肝的流行是一个重大的公共卫生问题,疾病负担沉重。在中国,目前乙肝的诊断和治疗率与世界卫生组织(WHO)设定的到2030年消除病毒性肝炎作为公共卫生威胁的目标之间仍存在很大差距。为实现WHO目标和《“健康中国2030”规划纲要》目标,中国预防医学会组织临床医学、公共卫生和临床检验医学领域的国内专家,在综合复习国内外相关指南和文献的基础上,经过多轮讨论,制定了《成人乙型肝炎病毒感染筛查、检测及管理专家建议》,目的是推动成人乙型肝炎病毒(HBV)感染的普遍筛查,并为HBV感染者的疾病评估、治疗及长期随访管理以及HBV易感者的疫苗接种提供实践指导,从而促进消除乙肝威胁。